Unity Net Borrowings vs Depreciation Analysis

UBX Stock  USD 1.69  0.02  1.17%   
Unity Biotechnology financial indicator trend analysis is much more than just breaking down Unity Biotechnology prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Unity Biotechnology is a good investment. Please check the relationship between Unity Biotechnology Net Borrowings and its Depreciation accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.

Net Borrowings vs Depreciation

Net Borrowings vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Unity Biotechnology Net Borrowings account and Depreciation. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Unity Biotechnology's Net Borrowings and Depreciation is -0.48. Overlapping area represents the amount of variation of Net Borrowings that can explain the historical movement of Depreciation in the same time period over historical financial statements of Unity Biotechnology, assuming nothing else is changed. The correlation between historical values of Unity Biotechnology's Net Borrowings and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Borrowings of Unity Biotechnology are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Net Borrowings i.e., Unity Biotechnology's Net Borrowings and Depreciation go up and down completely randomly.

Correlation Coefficient

-0.48
Relationship DirectionNegative 
Relationship StrengthVery Weak

Net Borrowings

The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.

Depreciation

Depreciation indicates how much of Unity Biotechnology value has been used up. For tax purposes Unity Biotechnology can deduct the cost of the tangible assets it purchases as business expenses. However, Unity Biotechnology must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Unity Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Unity Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Unity Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more information on how to buy Unity Stock please use our How to Invest in Unity Biotechnology guide.Sales General And Administrative To Revenue is likely to rise to 83.88 in 2025, whereas Selling General Administrative is likely to drop slightly above 18.9 M in 2025.
 2022 2023 2024 2025 (projected)
Total Operating Expenses57.8M25.0M28.7M27.3M
Cost Of Revenue2.2M19.7M17.7M14.1M

Unity Biotechnology fundamental ratios Correlations

0.870.660.690.350.550.280.28-0.010.8-0.310.370.610.630.840.77-0.26-0.350.140.060.05-0.3-0.080.210.890.6
0.870.730.870.50.70.340.4-0.180.95-0.510.390.730.760.750.84-0.08-0.620.3-0.270.29-0.590.180.490.740.73
0.660.730.85-0.010.830.770.81-0.720.72-0.790.730.220.440.280.520.46-0.790.78-0.460.73-0.740.650.760.360.74
0.690.870.850.150.780.560.74-0.510.89-0.860.570.530.530.440.760.3-0.910.59-0.540.6-0.890.460.810.470.77
0.350.5-0.010.150.03-0.39-0.440.450.540.26-0.340.610.770.550.47-0.460.03-0.36-0.03-0.330.04-0.37-0.20.530.09
0.550.70.830.780.030.650.68-0.70.73-0.690.590.470.440.260.530.57-0.720.81-0.360.7-0.690.620.740.320.66
0.280.340.770.56-0.390.650.9-0.870.29-0.730.97-0.080.23-0.20.320.62-0.610.85-0.170.89-0.570.820.76-0.180.68
0.280.40.810.74-0.440.680.9-0.890.4-0.940.87-0.030.12-0.160.360.69-0.840.87-0.460.91-0.820.810.9-0.120.65
-0.01-0.18-0.72-0.510.45-0.7-0.87-0.89-0.230.78-0.760.16-0.030.41-0.08-0.90.7-0.980.47-0.960.69-0.94-0.820.35-0.5
0.80.950.720.890.540.730.290.4-0.23-0.560.330.780.770.640.840.07-0.710.36-0.380.31-0.680.180.540.70.71
-0.31-0.51-0.79-0.860.26-0.69-0.73-0.940.78-0.56-0.71-0.14-0.20.04-0.47-0.640.96-0.790.64-0.840.95-0.72-0.950.0-0.64
0.370.390.730.57-0.340.590.970.87-0.760.33-0.710.040.33-0.130.470.51-0.580.75-0.020.8-0.540.660.7-0.10.72
0.610.730.220.530.610.47-0.08-0.030.160.78-0.140.040.70.610.77-0.18-0.310.00.02-0.08-0.31-0.210.170.640.56
0.630.760.440.530.770.440.230.12-0.030.77-0.20.330.70.50.84-0.13-0.330.110.030.15-0.3-0.010.230.510.56
0.840.750.280.440.550.26-0.2-0.160.410.640.04-0.130.610.50.59-0.62-0.06-0.290.09-0.33-0.02-0.4-0.110.950.23
0.770.840.520.760.470.530.320.36-0.080.84-0.470.470.770.840.59-0.1-0.530.170.010.22-0.51-0.010.430.590.66
-0.26-0.080.460.3-0.460.570.620.69-0.90.07-0.640.51-0.18-0.13-0.62-0.1-0.590.89-0.50.82-0.60.810.71-0.50.27
-0.35-0.62-0.79-0.910.03-0.72-0.61-0.840.7-0.710.96-0.58-0.31-0.33-0.06-0.53-0.59-0.740.75-0.771.0-0.67-0.93-0.11-0.68
0.140.30.780.59-0.360.810.850.87-0.980.36-0.790.750.00.11-0.290.170.89-0.74-0.480.94-0.720.910.85-0.20.59
0.06-0.27-0.46-0.54-0.03-0.36-0.17-0.460.47-0.380.64-0.020.020.030.090.01-0.50.75-0.48-0.50.76-0.57-0.640.06-0.22
0.050.290.730.6-0.330.70.890.91-0.960.31-0.840.8-0.080.15-0.330.220.82-0.770.94-0.5-0.760.960.91-0.330.56
-0.3-0.59-0.74-0.890.04-0.69-0.57-0.820.69-0.680.95-0.54-0.31-0.3-0.02-0.51-0.61.0-0.720.76-0.76-0.66-0.93-0.07-0.66
-0.080.180.650.46-0.370.620.820.81-0.940.18-0.720.66-0.21-0.01-0.4-0.010.81-0.670.91-0.570.96-0.660.82-0.410.48
0.210.490.760.81-0.20.740.760.9-0.820.54-0.950.70.170.23-0.110.430.71-0.930.85-0.640.91-0.930.82-0.110.66
0.890.740.360.470.530.32-0.18-0.120.350.70.0-0.10.640.510.950.59-0.5-0.11-0.20.06-0.33-0.07-0.41-0.110.3
0.60.730.740.770.090.660.680.65-0.50.71-0.640.720.560.560.230.660.27-0.680.59-0.220.56-0.660.480.660.3
Click cells to compare fundamentals

Unity Biotechnology Account Relationship Matchups

Unity Biotechnology fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets156.3M124.7M124.4M65.7M59.1M100.2M
Other Current Liab7.4M7.0M5.3M3.0M2.7M2.6M
Total Current Liabilities14.5M16.6M19.6M7.8M9.0M14.3M
Total Stockholder Equity82.9M59.6M66.8M28.4M32.7M31.0M
Net Tangible Assets120.7M82.9M59.6M66.8M76.9M57.5M
Property Plant And Equipment Net36.1M31.2M26.9M18.1M20.8M19.9M
Net Debt41.2M18.7M34.6M7.2M8.3M8.7M
Retained Earnings(339.3M)(400.0M)(460.0M)(484.4M)(435.9M)(457.7M)
Accounts Payable2.6M2.0M1.8M1.4M1.2M2.1M
Cash17.8M32.9M12.7M19.8M17.8M23.3M
Non Current Assets Total55.5M34.2M27.8M19.1M21.9M25.2M
Non Currrent Assets Other1.4M987K52K1.0M919.8K981.1K
Other Assets2.1M1.4M987K948K853.2K992.6K
Cash And Short Term Investments97.7M88.1M94.8M43.2M38.9M36.9M
Common Stock Shares Outstanding5.1M5.6M9.5M14.8M17.0M17.8M
Short Term Investments79.9M55.2M82.1M23.4M21.1M20.0M
Liabilities And Stockholders Equity156.3M124.7M124.4M65.7M59.1M100.2M
Non Current Liabilities Total59.0M48.5M37.9M29.5M26.5M33.0M
Capital Surpluse324.7M366.7M422.4M527.0M606.1M636.4M
Other Current Assets6.3M2.4M1.5M1.8M1.6M2.1M
Other Stockholder Equity422.2M459.6M500.8M512.8M589.7M355.1M
Total Liab73.4M65.1M57.5M37.3M33.6M43.4M
Property Plant And Equipment Gross12.6M31.2M26.9M27.3M31.4M17.9M
Total Current Assets100.9M90.5M96.5M46.6M41.9M81.9M
Accumulated Other Comprehensive Income5K(44K)(251K)(24K)(27.6K)(29.0K)
Property Plant Equipment16.6M36.1M31.2M7.8M9.0M16.9M
Net Invested Capital107.4M81.0M87.2M28.4M25.6M24.3M
Net Working Capital86.4M73.9M76.9M38.8M34.9M33.1M
Short Long Term Debt Total59.0M51.6M47.4M27.0M31.0M33.9M
Short Term Debt4.5M7.4M12.6M3.5M4.0M6.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Unity Stock Analysis

When running Unity Biotechnology's price analysis, check to measure Unity Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Unity Biotechnology is operating at the current time. Most of Unity Biotechnology's value examination focuses on studying past and present price action to predict the probability of Unity Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Unity Biotechnology's price. Additionally, you may evaluate how the addition of Unity Biotechnology to your portfolios can decrease your overall portfolio volatility.